DD107461A5 - - Google Patents

Info

Publication number
DD107461A5
DD107461A5 DD172669A DD17266973A DD107461A5 DD 107461 A5 DD107461 A5 DD 107461A5 DD 172669 A DD172669 A DD 172669A DD 17266973 A DD17266973 A DD 17266973A DD 107461 A5 DD107461 A5 DD 107461A5
Authority
DD
German Democratic Republic
Application number
DD172669A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD107461A5 publication Critical patent/DD107461A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD172669A 1972-08-02 1973-08-01 DD107461A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (1)

Publication Number Publication Date
DD107461A5 true DD107461A5 (en:Method) 1974-08-05

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
DD172669A DD107461A5 (en:Method) 1972-08-02 1973-08-01

Country Status (29)

Country Link
US (1) US3893999A (en:Method)
JP (1) JPS5235726B2 (en:Method)
AR (1) AR195350A1 (en:Method)
AT (1) AT341684B (en:Method)
AU (1) AU474015B2 (en:Method)
BE (1) BE802981A (en:Method)
CA (1) CA1006872A (en:Method)
CH (1) CH592112A5 (en:Method)
CS (1) CS195254B2 (en:Method)
DD (1) DD107461A5 (en:Method)
DE (1) DE2336401C3 (en:Method)
DK (1) DK131868C (en:Method)
ES (1) ES417377A1 (en:Method)
FI (1) FI52466C (en:Method)
FR (1) FR2194425B1 (en:Method)
GB (1) GB1425384A (en:Method)
HK (1) HK31580A (en:Method)
HU (1) HU167266B (en:Method)
IE (1) IE37913B1 (en:Method)
IL (1) IL42764A (en:Method)
MX (1) MX4544E (en:Method)
NL (1) NL152864B (en:Method)
NO (1) NO137941C (en:Method)
PL (1) PL87381B1 (en:Method)
RO (1) RO63451A (en:Method)
SE (1) SE400085B (en:Method)
SU (1) SU646915A3 (en:Method)
YU (1) YU36037B (en:Method)
ZA (1) ZA734876B (en:Method)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
US4109079A (en) * 1975-10-16 1978-08-22 Yamasa Shoyu Kabushiki Kaisha Stabilized s-adenosyl-l-methionine preparations
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
DE3874352T2 (de) * 1987-10-09 1992-12-17 Mario De Rosa Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
WO2006079212A1 (en) 2005-01-26 2006-08-03 Diamedica Inc. Use of s-adenosylmethionme, vitamin e, and vitamin c for the treatment of oxidative liver injury or insulin resistance
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060026A1 (it) * 2006-01-10 2007-07-11 Truffini & Regge Farmaceutici Srl Composizioni per uso rale a base di s-adenosilmetionina e processo per il loro ottenimento
ITMI20060629A1 (it) 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
AU2008210327B2 (en) * 2007-01-31 2011-06-16 Methylation Sciences International Srl Extended release pharmaceutical formulations of S-adenosylmethionine
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US20110027342A1 (en) 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
EP2696879A4 (en) * 2011-04-15 2014-11-26 Scimar Ltd USE OF S-ADENOSYLMETHIONINE, VITAMIN E AND VITAMIN C IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DYSFUNCTION
AU2013332209B2 (en) 2012-10-17 2016-02-04 Methylation Sciences International Srl Compositions comprising S-adenosylmethionine and a gallic acid ester
US9534010B2 (en) 2013-01-16 2017-01-03 Hebert Sam-E Llc Stable indole-3-propionate salts of S-adenosyl-L-methionine
US12239623B2 (en) 2023-05-15 2025-03-04 Bonafide Health, Llc Sleep-improving compositions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Also Published As

Publication number Publication date
AR195350A1 (es) 1973-09-28
IL42764A (en) 1976-04-30
US3893999A (en) 1975-07-08
AU474015B2 (en) 1976-07-08
AT341684B (de) 1978-02-27
FI52466C (fi) 1977-09-12
CH592112A5 (en:Method) 1977-10-14
JPS4992215A (en:Method) 1974-09-03
CS195254B2 (en) 1980-01-31
BE802981A (fr) 1973-11-16
IE37913B1 (en) 1977-11-09
SE400085B (sv) 1978-03-13
HK31580A (en) 1980-06-20
DE2336401A1 (de) 1974-02-14
RO63451A (fr) 1978-07-15
JPS5235726B2 (en:Method) 1977-09-10
YU36037B (en) 1981-11-13
HU167266B (en:Method) 1975-09-27
IL42764A0 (en) 1974-01-14
NL7310706A (en:Method) 1974-02-05
DK131868C (da) 1976-03-08
CA1006872A (en) 1977-03-15
SU646915A3 (ru) 1979-02-05
DE2336401C3 (de) 1980-03-13
FR2194425B1 (en:Method) 1976-04-09
NO137941B (no) 1978-02-13
GB1425384A (en) 1976-02-18
FI52466B (en:Method) 1977-05-31
ZA734876B (en) 1974-06-26
DK131868B (da) 1975-09-15
DE2336401B2 (de) 1979-07-12
AU5868073A (en) 1975-01-30
YU203073A (en) 1981-04-30
ATA664173A (de) 1977-06-15
ES417377A1 (es) 1976-02-16
MX4544E (es) 1982-06-08
IE37913L (en) 1974-02-02
FR2194425A1 (en:Method) 1974-03-01
NO137941C (no) 1978-05-31
PL87381B1 (en:Method) 1976-06-30
NL152864B (nl) 1977-04-15

Similar Documents

Publication Publication Date Title
FI52466B (en:Method)
FR2174958A1 (en:Method)
JPS4967807A (en:Method)
JPS4934237U (en:Method)
JPS4923646A (en:Method)
JPS4985000U (en:Method)
JPS4873532A (en:Method)
JPS4933730A (en:Method)
JPS5255941Y2 (en:Method)
JPS4931934U (en:Method)
JPS4924140A (en:Method)
JPS4877575A (en:Method)
JPS48102322U (en:Method)
JPS48100506U (en:Method)
CH580838B5 (en:Method)
CH573117A5 (en:Method)
BG18169A1 (en:Method)
CH582354A5 (en:Method)
CH570144A5 (en:Method)
CH579580A5 (en:Method)
CH574970A5 (en:Method)
NL7201996A (en:Method)
CH572830A5 (en:Method)
CH573764A5 (en:Method)
CH573714A5 (en:Method)